legislation: 100-s-143
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100-s-143 | 100 | s | 143 | Compassionate Pain Relief Act | Health | 1987-01-06 | 1987-01-20 | Committee on Labor and Human Resources requested executive comment from Health and Human Services Department, OMB, GAO. | Senate | Sen. Inouye, Daniel K. [D-HI] | HI | D | I000025 | 17 | Compassionate Pain Relief Act - Directs the Secretary of Health and Human Services to establish a 60-month program under which parenteral diacetylmorphine shall be made available through hospital and other prescribed pharmacies for the relief of pain from terminal cancer (as defined by this Act). Directs the Secretary to provide for the manufacture of such drug. Permits physicians registered under the Controlled Substances Act to prescribe such drug. States that for purposes of such program the Federal Food, Drug, and Cosmetic Act and titles II and III of the Comprehensive Drug Abuse Prevention and Control Act of 1970 shall not apply with respect to: (1) the importing of opium; and (2) the manufacture, distribution, and dispensing of parenteral diacetylmorphine. Requires: (1) the Secretary to make program reports to specified congressional committees; and (2) the Comptroller General of the United States to make a program report to such committees 56 months after the program is established. Requires the Secretary to report to specified congressional committees concerning: (1) the extent of research activities in the management of pain which have received funds through the National Institutes of Health; (2) the ways in which the Federal Government supports the training of health personnel in pain management; and (3) recommendations for expanding and improving the training of health personnel in pain management. Permits the Secretary at any time six months after implementation of the program to modify or terminate the program. | 2025-08-28T20:07:22Z | https://www.congress.gov/bill/100th-congress/senate-bill/143 |